These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 103841)

  • 1. Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa.
    Pier GB; Sidberry HF; Sadoff JC
    Infect Immun; 1978 Dec; 22(3):919-25. PubMed ID: 103841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction in mice of cell-mediated immunity to Pseudomonas aeruginosa by high molecular weight polysaccharide and vinblastine.
    Pier GB; Markham RB
    J Immunol; 1982 May; 128(5):2121-5. PubMed ID: 6174622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-molecular-weight polysaccharide antigen from Pseudomonas aeruginosa immunotype 2.
    Pier GB; Sidberry HF; Sadoff JC
    Infect Immun; 1981 Nov; 34(2):461-8. PubMed ID: 6171520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical characterization of high-molecular-weight polysaccharide from Fisher immunotype 3 Pseudomonas aeruginosa.
    Pier GB; Pollack M; Cohen M
    Infect Immun; 1984 Aug; 45(2):309-13. PubMed ID: 6430805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the antibody response in inbred mice to a high-molecular-weight polysaccharide from Pseudomonas aeruginosa immunotype 1.
    Markham RB; Pier GB
    Infect Immun; 1983 Jul; 41(1):232-6. PubMed ID: 6407998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic basis for mouse protection provided by high-molecular-weight polysaccharide from immunotype 1 Pseudomonas aeruginosa.
    Markham RB; Pier GB
    Rev Infect Dis; 1983; 5 Suppl 5():S957-62. PubMed ID: 6419317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate).
    Hatano K; Goldberg JB; Pier GB
    Infect Immun; 1995 Jan; 63(1):21-6. PubMed ID: 7528730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-protection by Pseudomonas aeruginosa polysaccharides.
    Pier GB
    Infect Immun; 1982 Dec; 38(3):1117-22. PubMed ID: 6185423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with Pseudomonas aeruginosa high-molecular-weight polysaccharides prevents death from Pseudomonas burn infections in mice.
    Pollack M; Pier GB; Prescott RK
    Infect Immun; 1984 Feb; 43(2):759-60. PubMed ID: 6420347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis and immunogenicity of Pseudomonas aeruginosa immunotype 2 high molecular weight polysaccharide.
    Pier GB; Bennett SE
    J Clin Invest; 1986 Feb; 77(2):491-5. PubMed ID: 3080477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of a high-molecular-weight polysaccharide from the slime of Pseudomonas aeruginosa.
    Pier GB; Sidberry HF; Zolyomi S; Sadoff JC
    Infect Immun; 1978 Dec; 22(3):908-18. PubMed ID: 103840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of a nontoxic polysaccharide-protein conjugate that induces active immunity and passively protective antibody against Pseudomonas aeruginosa immunotype 1 in mice.
    Tsay GC; Collins MS
    Infect Immun; 1984 Jul; 45(1):217-21. PubMed ID: 6429046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cytophilic IgG3 antibody in T cell-mediated resistance to infection with the extracellular bacterium, Pseudomonas aeruginosa.
    Markham RB; Pier GB; Schreiber JR
    J Immunol; 1991 Jan; 146(1):316-20. PubMed ID: 1898604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa.
    Schreiber JR; Patawaran M; Tosi M; Lennon J; Pier GB
    J Immunol; 1990 Feb; 144(3):1023-9. PubMed ID: 2104908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against fatal Pseudomonas aeruginosa burn wound sepsis by immunization with lipopolysaccharide and high-molecular-weight polysaccharide.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1984 Mar; 43(3):795-9. PubMed ID: 6698608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa immunotype 5 polysaccharide-toxin A conjugate vaccine.
    Cryz SJ; Furer E; Sadoff JC; Germanier R
    Infect Immun; 1986 Apr; 52(1):161-5. PubMed ID: 3082756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of the protective response induced by the slime layer of Pseudomonas aeruginosa.
    Mates A; Zand P
    J Hyg (Lond); 1974 Aug; 73(1):75-84. PubMed ID: 4213979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemistry of Pseudomonas aeruginosa lipopolysaccharides and high-molecular-weight polysaccharides.
    Pier GB
    Rev Infect Dis; 1983; 5 Suppl 5():S950-6. PubMed ID: 6197738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.